Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2806_Библиотеки_им_академика_М_И_Перельмана

There are few studies that focus their investi­gation on quality of life in patients who undergo below-knee interventions via endovascular means. Dua etal. reviewed tibial and pedal endo­vascular interventions in patients with CLTI [34]. This single center reviewed outcomes after lower extremity endovascular revascularizations that included tibiopedal revascularization between 2016 and 2017. Some of these patients also have more proximal endovascular interventions in the same procedure. They reported low subsequent major amputation rates (4% at 6months) and no adverse events in 30 days after procedure. Of note, QoL scores improved over time after endo­vascular tibiopedal revascularization with higher Stark QoL scores at 1, 3, and 6 months post­revascularization. It is important to note that the Stark QoL questionnaire was assessed at every post-procedure visit with high respondent rates likely owing to the fact that the questionnaire contains primarily pictures and minimal words, and it takes, on average, less than 5min to com­plete [35]. As well, the multicenter, randomized Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease (ACHILLES) trial reviewed endovascular infrapopliteal interven­tions for CLTI using either sirolimus eluting stents (SES) or balloon angioplasty (BAP) [36]. QoL was assessed using EQ-5D in the 200 enrolled patients and found improvement in most domains in during the study period. These improvements were noted primarily within the rst 6weeks after revascularization, and notably the domains of self-care and activity did not improve. No signicant difference was noted

It is vital that we begin to nd the balance of technical measures to patient-reported outcome